Genprex Inc Stock - GNPX Share Price Today, News and Discussion

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

17

Current Price	$1.78
Prev Close	$1.71
Open	$1.75
Dividend Yield	0.00%
50-Day Moving Average	$1.31
Beta	1.44
Avg. Volume	296,813.65
PE Ratio	N/A

52-Week High	$2.67
52-Week Low	$0.97
Market Capitalization	$75.88M
EPS	-$0.4729
Price to Book	2.76
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-1.86

No GNPX news at the moment.

GNPX Genprex Inc

About

Feed

Fundamentals

News